ICON acquired PRA Health Sciences in a $12B deal ... Base case number project ~18% CAGR to FY'26E getting us to $559 per share at the same 20x multiple. Revise to buy. Critically, on the 7% ...

Even though the CRO market expects a challenging outlook for 2025, in the next 9–10 years, the CRO market expects to grow at a 5.8%-7.42% CAGR. ICON has seen a decline in its non-current bank ...

But on the bright side, you can make far more than 100% on a really good stock. Long term ICON Public Limited Company (NASDAQ:ICLR) shareholders would be well aware of this, since the stock is up ...

The compound annual growth rate, or CAGR, of an investment or other unit of value is the average annual amount it grows over a period of years assuming profits are reinvested during the period.